SCHEMBL1012732

SCHEMBL1012732

Clc1nc(OCc2ccccc2)nc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.50
PDE5A O76074 2/20 0.49
ELANE P08246 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.45
METAP1 P53582 1/20 0.44
STAT3 P40763 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
CNR1 P21554 1/20 0.41
ACHE P22303 1/20 0.41
CNR2 P34972 1/20 0.41
HRH4 Q9H3N8 1/20 0.41
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4725521 0.82 MAOB (0.48) HTTSMN1; SMN2MAOBEGFRERBB2
SCHEMBL6471210 0.80 EGFR (0.50) L3MBTL1SMN1; SMN2MAOBEGFRERBB2
SCHEMBL28023475 0.79 PDE5A (0.59) PDE5AELANEL3MBTL1HRH4ALDH1A1
SCHEMBL11009131 0.78 TSHR (0.52) PIN1PDE5AL3MBTL1STAT3HTT
Hydrochloric Acid SCHEMBL28023495 0.78 PDE5A (0.57) PDE5AELANEL3MBTL1HRH4ALDH1A1
SCHEMBL8682782 0.78 TSHR (0.46) METAP1PDE4APDE4BPDE4CPDE4D
SCHEMBL578063 0.77 PIN1 (0.49) PIN1PDE5AL3MBTL1SMN1; SMN2MAOA
SCHEMBL1639465 0.77 PIN1 (0.49) PIN1PDE5AL3MBTL1SMN1; SMN2MAOA
SCHEMBL10615700 0.76 PIN1 (0.50) PIN1PDE5AELANEL3MBTL1CLK4
SCHEMBL28430438 0.76 CYP3A4 (0.49) MAOAMAOBACHEEGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268623-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2011-01-05 EP disclosed
WO-2009117080-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATON (US) 2009-09-24 WO disclosed